The pharmaceutical industry has been a fundamental pillar of the global economy for a considerable time, and companies are continuously striving to innovate and outshine their competitors.
Thus, as we approach the end of 2023, this article assesses the fundamentals of two pharma companies, Pfizer Inc. (PFE) and Taro Pharmaceutical Industries Ltd. (TARO), to determine which stock is better equipped to dominate the final quarter of this year.
